Interview with the magazine “Laborjournal”
Research and development without or with significantly less animal testing must be possible. We at Dynamic42 are convinced of this and at the same time on the way to realising this goal with the help of our organ-on-chip technology.
In an interview with the trade journal “Laborjournal”, our managing directors Martin Raasch and Knut Rennert explain how the Dynamic42 biotech chips work and how the “mini-organs” used contribute to reducing animal experiments.
The article also gives exciting insights into the background of our company and explains what our company name means.
Read the full interview in German: Laborjounal online: Nerdy names and runny noses
Recommendation: The magazine reported in more detail about our technology in the print edition. Laborjournal issue 03/22 (page 46/47)
Read more News:
We are delighted to announce that Dr. Juliane Fischer has joined our team and will from now on heading all Marketing efforts at Dynamic42.Read More
Following their Master's studies, Daria and Sophie join our lab team as research assistants.Read More
The RUBIN Alliance "ATHANA" (antifungal therapy approaches with nanoparticle-based targeting of drugs) is developing innovative therapeutic approaches for the treatment of infectious diseases, in particular fungal infections.Read More